Factors Associated with Discontinuation of Complementary and Alternative Medicine among Korean Cancer Patients |
Kim, So Young
(National Cancer Control Research Institute, National Cancer Center)
Kim, Kyung Sook (Korea Institute for Healthcare Accreditation) Park, Jong Hyock (National Cancer Control Research Institute, National Cancer Center) Shin, Ji-Yeon (National Cancer Control Research Institute, National Cancer Center) Kim, Sung Kyeong (National Cancer Control Research Institute, National Cancer Center) Park, Jae Hyun (Department of Social and Preventive Medicine, Sungkyunkwan University School of Medicine) Park, Eun Cheol (Department of Preventive Medicine & Institute of Health Services Research, Yonsei University College of Medicine) Seo, Hong Gwan (National Cancer Control Research Institute, National Cancer Center) |
1 | National Center for Complementary and Alternative Medicine (NCCAM) (2012). What is complementary and alternative medicine?. http://nccam.nih.gov/health/whatiscam/ (24 Oct 2012, date last accessed). |
2 | Nazik E, Nazik H, Api M, et al (2012). Complementary and alternative medicine use by gynecologic oncology patients in Turkey. Asian Pac J Cancer Prev, 13, 21-5. DOI ScienceOn |
3 | Niggemann B, Gruber C (2003). Side-effects of complementary and alternative medicine. Allergy, 58, 707-16. DOI ScienceOn |
4 | Paltiel O, Avitzour M, Peretz T, et al (2001). Determinants of the use of complementary therapies by patients with cancer. J Clin Oncol, 19, 2439-48. |
5 | Porter M, Kolva E, Ahl R, et al(2008). Changing patterns of CAM use among prostate cancer patients two years after diagnosis: reasons for maintenance or discontinuation. Complementary Therapies in Medicine, 16, 318-24. DOI ScienceOn |
6 | Saibul N, Shariff ZM, Rahmat A, et al(2012). Use of complementary and alternative medicine use among breast cancer survivors. Asian Pac J Cancer Prev, 13, 4081-6. DOI ScienceOn |
7 | Samur M, Bozcuk HS, Kara A, et al (2001). Factors associated with utilization of nonproven cancer therapies in Turkey. Support Care Cancer, 9, 452-8. DOI ScienceOn |
8 | Schmidt K, Ernst E (2004). Assessing websites on complementary and alternative medicine for cancer. Ann Oncol, 15, 733-42. DOI ScienceOn |
9 | Shin V, Chiang JYL, Chan A (2009). Complementary and alternative medicine (CAM) usage in Singaporean adult cancer patients. Ann Oncol, 20, 752-7. DOI ScienceOn |
10 | Shumay DM, Maskarinec G, Gotay CC, et al(2002). Determinants of the degree of complementary and alternative medicine use among patients with cancer. The Journal of Alternative and Complementary Medicine, 8, 661-71. DOI ScienceOn |
11 | Siegel R, Naishadham D, Jemal A (2012). Cancer Statistics, 2012. CA: A Cancer Journal for Clinicians, 62, 10-29. DOI ScienceOn |
12 | Stickel F, Patsenker E, Schuppan D (2005). Herbal hepatotoxicity. J Hepatology, 43, 901-10. DOI ScienceOn |
13 | Swarup AB, Barrett W, Jazieh AR (2006). The use of complementary and alternative medicine by cancer patients undergoing radiation therapy. Am J Clin Oncol, 29, 468-73. DOI ScienceOn |
14 | Takahasi M, Kai I, Muto T (2012). Discrepancies Between Public Perceptions and Epidemiological Facts Regarding Cancer Prognosis and Incidence in Japan: An Internet Survey. Jpn J Clin Oncol doi:10.1093/jjco/hys125. DOI |
15 | Tasaki K, Maskarinec G, Shumay DM, et al (2002). Communication between conventional medical doctors and cancer patients about complementary and alternative medicine: exploring patients' perspectives. Psycho-Oncology, 11, 212-20. DOI |
16 | Yates JS, Mustian KM, Morrow GR, et al (2005). Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer, 13, 806-11. DOI ScienceOn |
17 | Er O, Mistik S, Ozkan M, et al(2008). Factors related to complementary/ alternative medicine use among cancer patients in central Anatolia. Tumori, 94, 833-7. |
18 | Harris P, Finlay IG, Cook A, et al (2003). Complementary and alternative medicine use by patients with cancer in Wales: a cross sectional survey. Complementary Therapies in Medicine, 11, 249-53. DOI ScienceOn |
19 | Hyodo I, Amano N, Eguchi K, et al (2005). Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol, 23, 2645-54. |
20 | Kim SG, Park EC, Park JH, et al (2007). Initiation and discontinuation of complementary therapy among cancer patients. J Clin Oncol, 25, 5267-74. DOI ScienceOn |
21 | Markman M (2003). Safety issues in using complementary and alternative medicine. J Clin Oncol, 20(18suppl), 39- 41. |
22 | Molassiotis A, Xu M (2004). Quality and safety issues of webbased information about herbal medicines in the treatment of cancer. Complementary Therapies in Medicine, 12, 217-27. DOI ScienceOn |
23 | Molassiotis A, Fernandez-Ortega P, Pud D, et al (2005). Complementary and alternative medicine use in colorectal cancer patients in seven European countries. Complementary Therapies in Medicine, 13, 251-7. DOI ScienceOn |
24 | Molassiotis A, Panteli V, Patiraki E, et al (2006). Complementary and alternative medicine use in lung cancer patients in eight European countries. Complementary Therapies in Clinical Practice, 12, 34-9. DOI ScienceOn |
25 | Montazeri A, Sajadian A, Ebrahimi M, et al (2007). Factors predicting the use of complementary and alternative therapies among cancer patients in Iran. European Journal of Cancer Care, 16, 144-9. DOI ScienceOn |
26 | Boon H, Stewart M, Kennard MA, et al (2000). Use of complementary/ alternative medicine by breast cancer survivors in Ontario. Prevalence and perceptions. J Clin Oncol, 18, 2515-21. |
27 | Choi JY, Chang YJ, Hong YS, et al (2012). Complementary and alternative medicine use among cancer patients at the end of life: Korea national study. Asian Pac J Cancer Prev, 13, 1419-24. DOI ScienceOn |
28 | Chung HJ, Kim MR, Bae JS, et al (2006). Complementary and alternative medicine in patients with breast cancer. J Breast Cancer, 9, 361-6. DOI ScienceOn |
29 | Crocetti E, Crotti N, Feltrin A, et al (1998). The use of complementary therapies by breast cancer patients attending conventional treatment. Eur J Cancer, 34, 324-8. DOI ScienceOn |
30 | Donovan RJ, Jalleh G, Jones SC (2003). The word 'cancer': reframing the context to reduce anxiety arousal. Aust N Z Public Health, 27, 291-3. DOI ScienceOn |
31 | Downer SM, Cody MM, McCluskey P, et al (1994). Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ, 309, 86-9. DOI ScienceOn |